
Ciscure 0.25mg Injection
Marketer
Emcure Pharmaceuticals Ltd
Salt Composition
Cetrorelix (0.25mg)
Overview Ciscure 0.25mg Injection
GnRH antagonist Cetrorelix 0.25mg injection treats female infertility. It suppresses premature egg release, preventing ovulation. Administered subcutaneously by a healthcare professional, self-injection is prohibited. Home injection guidance will be provided by your doctor or nurse. Dosage and frequency vary depending on your condition; your physician determines the optimal treatment plan. Continue using as prescribed. Common side effects include injection site reactions (redness, itching, irritation), nausea, and vomiting. Rotate injection sites daily to minimize irritation. Report dizziness, fainting, abdominal pain, or persistent vomiting immediately. Before starting treatment, inform your doctor of any liver or kidney disease, or breastfeeding. Disclose all other medications you are using, as interactions can affect Cetrorelix's efficacy.
Uses of Ciscure 0.25mg Injection
Inability to conceive in women
Major Benefits of Ciscure 0.25mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Ciscure 0.25mg Injection:
- Nausea
- Ovarian hyperstimulation syndrome
- Injection site reactions (pain, swelling, redness)
- Itching
- Irritation
- Vomiting
- Lower abdominal pain
How to use Ciscure 0.25mg Injection:
The medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Ciscure 0.25mg Injection works:
During infertility treatment in women, the premature discharge of immature, unfertilizable eggs can occur. Ciscures 0.25mg Injection inhibits a naturally occurring hormone, thereby preventing this premature ovarian egg release.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Ciscure 0.25mg Injection concurrently with alcohol. Physician consultation is recommended.
PregnancyUNSAFE
Administering Ciscure 0.25mg Injection to pregnant individuals poses a substantial risk. Pregnant women should consult their physician before use, given that research in animals and pregnant humans has revealed considerable adverse effects on fetal development.
Breast feedingUNSAFE
Administering Ciscure 0.25mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingSAFE
Administration of Ciscure 0.25mg Injection typically does not impair driving ability.
KidneyCAUTION
For individuals with kidney impairment, administering Ciscure 0.25mg Injection requires careful consideration and potential dosage modification. Physician consultation is advised. Ciscure 0.25mg Injection is contraindicated in patients exhibiting severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Ciscure 0.25mg Injection cautiously, as dose modification may be necessary. Physician consultation is advised.
What if you forget to take Ciscure 0.25mg Injection :
Should you forget a Ciscure 0.25mg Injection, seek your physician's advice.
Facts to Know About Ciscure 0.25mg Injection
| Label | Value |
|---|---|
| Chemical Category | Peptide chains |
| Developing Habits | No. |
| Treatment Category | Endocrine Signals |
| Actions | GnRH receptor antagonists |
